Express Scripts Holding Co (ESRX)

ESRX (NASDAQ:Health Services) EQUITY
$59.76
pos +0.00
+0.00%
Today's Range: 59.57 - 60.33 | ESRX Avg Daily Volume: 5,182,200
Last Update: 05/26/17 - 4:00 PM EDT
Volume: 0
YTD Performance: -13.13%
Open: $0.00
Previous Close: $60.09
52 Week Range: $57.80 - $80.02
Oustanding Shares: 593,527,000
Market Cap: 35,665,037,430
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 7 7
Moderate Buy 0 0 0 0
Hold 9 9 8 9
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 1
Mean Rec. 2.49 2.49 2.37 2.25
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 10.97
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
10.97 11.00 29.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-16.48% -20.01% -14.80%
GROWTH 12 Mo 3 Yr CAGR
Revenue -1.40 0.00 -0.01
Net Income 37.10 0.80 0.21
EPS 51.40 1.40 0.33
Earnings for ESRX:
EBITDA 7.24B
Revenue 100.29B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $1.71 $1.89 $6.97 $7.67
Number of Analysts 11 11 14 13
High Estimate $1.73 $1.96 $7.01 $8.02
Low Estimate $1.70 $1.86 $6.90 $7.50
Prior Year $1.57 $1.74 $6.39 $6.97
Growth Rate (Year over Year) 9.15% 8.78% 9.05% 10.08%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Paul Price

 | Apr 27, 2017 | 7:00 AM EDT
Fallout from dispute with Anthem, its largest customer, presents an opportunity.
RMPIA

bearishExpress Scripts Cut to Hold at Edward Jones

Apr 26, 2017 | 9:02 AM EDT
Edward Jones downgraded Express Scripts to "Hold" from "Buy."
RMPIA
By

Doug Kass

 | Apr 25, 2017 | 3:17 PM EDT
* Biotech (Allergan (AGN) , Celgene (CELG) and Gilead Sciences (GILD) ) * Speculative biotech ( ZIOPHARM Oncology (ZIOP) ,   SAGE Therapeutics (SAGE) , Intrexon (XON) , Valeant Pharmaceuticals (VRX) ,   ACADIA Pharmaceuticals (ACAD) , FibroGen  (FGEN) ). * DuPont (DD) , Netflix (NFLX) , Baidu (BIDU) , Radian (RDN) and Biogen   (BIIB) . * New tech - (T)FANG (TSLA) , (FB) , (AAPL) , (NFLX) , (GOOGL) . * Chipotle Mexican Grill (
RMPIA
By

Paul Price

 | Apr 11, 2017 | 10:00 AM EDT
Its earnings are more than double what they were five years ago, but the stock price is the same.
RMPIA

bearishExpress Scripts downgraded at Wells

Mar 15, 2017 | 6:49 AM EDT
ESRX was downgraded from Market Perform to Underperform, Wells Fargo said. Loss of the Anthem contract could hurt annual earnings by 20% to 40%.
RMPIA
By

Jim Collins

 | Jan 12, 2017 | 4:00 PM EST
The stock has taken a beating, but users of Afrezza are loyal to the drug.
RMPIA
By

Doug Kass

 | Dec 27, 2016 | 10:00 AM EST
Six reasons why the Nasdaq 100 ETF seems ready to pull back.
RMPIA
By

Doug Kass

 | Dec 27, 2016 | 7:00 AM EST
Microsoft (MSFT) , which makes up about 8.6% of the index. Amazon (AMZN) , which has about a 6.4% weighting. Cisco (CSCO) , which accounts for about 2.7% on QQQ. I've previously written that I'm bearish on Cisco on an intermediate-term basis. Non-Tech QQQ Stocks Look Iffy, Too Some non-tech QQQ components could weigh down the ETF in 2017 as well. These include biotech and health care companies such as Amgen (AMGN) , Biogen (BIIB) , Celgene (CELG) , Express Scripts (ESRX) and others, which all could suffer if Trump tries to limit drug-price increases. Comcast (CMCSA) also represents a relatively large QQQ weighting (about 3%), but the cable giant could suffer from continued "cord cutting" by consumers. Tax Cuts Won't Help QQQ Stocks Trump's plan to lower the effective U.S. corporate tax rate won't materially benefit QQQ components. After all, large tech and health care firms in the Nasdaq 100 already g
RMPIA
By

Guy Ortmann

 | Nov 14, 2016 | 12:27 PM EST
What stocks have changed direction in the past week.
RMPIA

bullishExpress Scripts upgraded at Deutsche

Nov 4, 2016 | 7:16 AM EDT
ESRX was upgraded from Sell to Hold, Deutsche Bank said. Valuation call, based on a $70 price target.
DIS has been green since the opening bell and is trading at its best levels of the week wi...
Looks like RUTH will finish the week at new 2017 highs.  Still has room to run, not o...
A big THANK YOU to all the men and women in uniform this weekend, and for those who served...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.